Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 516, pseudogene (RN7SL516P)

Target
RN7SL516P
Molecular classification
Other, Pseudogene, Non-coding RNA pseudogene
01

Overview

RN7SL516P is a processed pseudogene of the 7SL cytoplasmic RNA gene in humans. 7SL RNA is the RNA component of the signal recognition particle (SRP) complex, which is critical for targeting proteins to the endoplasmic reticulum during translation. However, RN7SL516P is a pseudogene, meaning it is a non-functional genomic DNA sequence derived from the ancestral functional 7SL RNA gene and does not produce a functional RNA or protein product. Pseudogenes like RN7SL516P generally arise from gene duplication or retrotransposition events and frequently lack regulatory elements or contain disabling mutations such as premature stop codons or truncations[1][6][7]. Some pseudogenes, especially those derived from non-coding RNAs, may be transcribed and have regulatory or decoy functions, for example by acting as miRNA sponges, but no specific function or disease association has been described or validated for RN7SL516P[4]. RN7SL516P is not considered a therapeutic target, does not encode a protein or active RNA, and is not associated with drug interactions, disease, or clinical biomarkers[1][6].

Other names
RN7SL516PRNA, 7SL, cytoplasmic 516, pseudogene
02

Mechanism of action

None (pseudogene; not a therapeutic target)

03

Biological functions

None (pseudogene; not known to have a direct functional product)
04

Disease associations

None clearly established; no known direct disease relevance
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 516, pseudogene (RN7SL516P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 516, pseudogene (RN7SL516P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call